Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanical and Oral Antibiotic Bowel Prep vs Oral Antibiotics Alone in Colorectal Surgery
NCT03042091Phase 1Unknown
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of polyethylene glycol 3350 + bisacodyl in surgical site infection (SSI) (2 arms), sponsored by Thomas Jefferson University. Primary endpoint: Incidence of post-operative surgical site infection at 30 days. Status: unknown.
02
Drugs
polyethylene glycol 3350 + bisacodyl
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03042091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03042091.